Immediate Impact

34 standout
Sub-graph 1 of 17

Citing Papers

Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Standout
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial
2025 Standout
1 intermediate paper

Works of Yuji Hamazaki being referenced

Dapagliflozin Influences Ventricular Hemodynamics and Exercise-Induced Pulmonary Hypertension in Type 2 Diabetes Patients ― A Randomized Controlled Trial ―
2020

Author Peers

Author Last Decade Papers Cites
Yuji Hamazaki 379 356 242 33 600
Mitsuaki Endo 349 431 289 34 685
E Uslenghi 249 405 189 45 568
Xiaofan Wu 321 342 250 36 646
Shogo Miyake 378 182 160 20 532
P. de Feyter 511 272 251 21 613
Mohammed El Mahdiui 235 516 305 34 652
John Kao 377 404 180 33 711
Dale T. Ashby 326 247 94 29 636
Won Yu Kang 342 462 245 36 669
Akihide Konishi 420 332 208 50 647

All Works

Loading papers...

Rankless by CCL
2026